The double beat comes with a guidance cut: full-year adjusted EBITDA is now seen broadly stable or slightly down, versus prior growth of 10% to 14% FX-neutral. The cause is Colombia, where an oncology risk-sharing contract blew through actuarial assumptions and has now been terminated.
Auna S.A.
AUNA at a Glance
- Market cap
- $288.8M
- P/E ratio
- 65.0
- Revenue (TTM)
- $4.9B
- Profit margin
- -0.2%
- EPS (TTM)
- $0.06
- 52-week range
- $4 – $6
- Street target
- $6.99
Headquartered in Rue Jean Monnet, Luxembourg Fiscal year ends December NYSE: AUNA aunainvestors.com
About Auna SA
Auna S.A. (NYSE: AUNA) is a Latin American healthcare platform operating in Mexico, Peru and Colombia, focused on prevention and high-complexity diseases such as oncology and cardiovascular care. It combines a horizontally integrated network of hospitals, outpatient, prevention and wellness facilities with a vertically integrated portfolio of prepaid oncology and selected general healthcare plans. Revenue comes from insurance (prepaid plans), healthcare services and the sale of medicines.
As of September 30, 2026, the healthcare network had 2,252 beds (excluding oncology beds), about 1.44 million plan memberships and roughly 3.2 million protected lives under Colombian risk-sharing agreements.
It reports four segments:
- **Oncosalud Peru:** prepaid oncology plans and cancer treatment.
- **Healthcare Services Peru:** a network of clinics and health centers.
- **Healthcare Services Colombia:** clinics including IMAT Oncomedica in Montería and facilities in Barranquilla, plus PGP risk-sharing contracts in Antioquia.
- **Healthcare Services Mexico:** the Monterrey network, including Doctors Hospital and OCA, plus the Auna Seguros insurance business.
Auna is also building Centro Ambulatorio Trecca in Lima under a 20-year capital-light public-private partnership with EsSalud, expected to open in late 2028. The company reports in Peruvian Soles under IFRS. Updated
Frequently Asked Questions
What does Auna SA do?
Auna S.A. (NYSE: AUNA) is a Latin American healthcare platform operating in Mexico, Peru and Colombia, focused on prevention and high-complexity diseases such as oncology and cardiovascular care.
What is the AUNA stock price target?
The Wall Street consensus 12-month price target for AUNA is $6.99.